# Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery

> **NCT03278548** · PHASE4 · COMPLETED · sponsor: **Fresenius Kabi** · enrollment: 2289 (actual)

## Conditions studied

- Hypovolaemia Due to Acute Blood Loss

## Interventions

- **DRUG:** Volulyte 6%
- **DRUG:** Ionolyte

## Key facts

- **NCT ID:** NCT03278548
- **Lead sponsor:** Fresenius Kabi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-28
- **Primary completion:** 2022-04-09
- **Final completion:** 2022-07-06
- **Target enrollment:** 2289 (ACTUAL)
- **Last updated:** 2024-01-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03278548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03278548, "Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03278548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*